Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Flowserve Corporation (FLS)

Page 1 of 2

Flowserve Corporation (NYSE:FLS) shareholders have witnessed an increase in activity from the world’s largest hedge funds in recent months.

In the 21st century investor’s toolkit, there are plenty of metrics investors can use to monitor their holdings. A pair of the most under-the-radar are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite investment managers can outpace the broader indices by a very impressive margin (see just how much).

Flowserve Corporation (NYSE:FLS)Just as beneficial, optimistic insider trading sentiment is another way to parse down the stock market universe. As the old adage goes: there are many motivations for an executive to cut shares of his or her company, but only one, very clear reason why they would buy. Many academic studies have demonstrated the impressive potential of this method if “monkeys” understand where to look (learn more here).

Consequently, it’s important to take a peek at the latest action surrounding Flowserve Corporation (NYSE:FLS).

What does the smart money think about Flowserve Corporation (NYSE:FLS)?

At Q1’s end, a total of 25 of the hedge funds we track were long in this stock, a change of 4% from the previous quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were increasing their holdings substantially.

Of the funds we track, Mario Gabelli’s GAMCO Investors had the largest position in Flowserve Corporation (NYSE:FLS), worth close to $183.3 million, accounting for 1.2% of its total 13F portfolio. Sitting at the No. 2 spot is Jean-Marie Eveillard of First Eagle Investment Management, with a $106.7 million position; the fund has 0.4% of its 13F portfolio invested in the stock. Some other peers that are bullish include David Cohen and Harold Levy’s Iridian Asset Management, Martin D. Sass’s MD Sass and Cliff Asness’s AQR Capital Management.

As one would reasonably expect, specific money managers have been driving this bullishness. Adage Capital Management, managed by Phill Gross and Robert Atchinson, initiated the biggest position in Flowserve Corporation (NYSE:FLS). Adage Capital Management had 12.6 million invested in the company at the end of the quarter. SAC Subsidiary’s Sigma Capital Management also made a $4.9 million investment in the stock during the quarter. The other funds with brand new FLS positions are Matthew Tewksbury’s Stevens Capital Management, Mike Vranos’s Ellington, and Jacob Gottlieb’s Visium Asset Management.

How have insiders been trading Flowserve Corporation (NYSE:FLS)?

Insider purchases made by high-level executives is at its handiest when the company we’re looking at has seen transactions within the past six months. Over the latest half-year time frame, Flowserve Corporation (NYSE:FLS) has seen zero unique insiders purchasing, and 3 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Flowserve Corporation (NYSE:FLS). These stocks are Roper Industries, Inc. (NYSE:ROP), Dover Corp (NYSE:DOV), Pentair, Ltd. Registered Share (NYSE:PNR), and Pall Corporation (NYSE:PLL). All of these stocks are in the diversified machinery industry and their market caps are similar to FLS’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!